Genome-wide association study of germline variants and breast cancer-specific mortality
Maria Escala-Garcia,Qi Guo,Thilo Dörk,Sander Canisius,Renske Keeman,Joe Dennis,Jonathan Beesley,Julie Lecarpentier,Manjeet K Bolla,Qin Wang,Jean Abraham,Irene L Andrulis,Hoda Anton-Culver,Volker Arndt,Paul L Auer,Matthias W Beckmann,Sabine Behrens,Javier Benitez,Marina Bermisheva,Leslie Bernstein,Carl Blomqvist,Bram Boeckx,Stig E Bojesen,Bernardo Bonanni,Anne-Lise Børresen-Dale,Hiltrud Brauch,Hermann Brenner,Adam Brentnall,Louise Brinton,Per Broberg,Ian W Brock,Sara Y Brucker,Barbara Burwinkel,Carlos Caldas,Trinidad Caldés,Daniele Campa,Federico Canzian,Angel Carracedo,Brian D Carter,Jose E Castelao,Jenny Chang-Claude,Stephen J Chanock,Georgia Chenevix-Trench,Ting-Yuan David Cheng,Suet-Feung Chin,Christine L Clarke,NBCS Collaborators,Emilie Cordina-Duverger,Fergus J Couch,David G Cox,Angela Cox,Simon S Cross,Kamila Czene,Mary B Daly,Peter Devilee,Janet A Dunn,Alison M Dunning,Lorraine Durcan,Miriam Dwek,Helena M Earl,Arif B Ekici,A Heather Eliassen,Carolina Ellberg,Christoph Engel,Mikael Eriksson,D Gareth Evans,Jonine Figueroa,Dieter Flesch-Janys,Henrik Flyger,Marike Gabrielson,Manuela Gago-Dominguez,Eva Galle,Susan M Gapstur,Montserrat García-Closas,José A García-Sáenz,Mia M Gaudet,Angela George,Vassilios Georgoulias,Graham G Giles,Gord Glendon,David E Goldgar,Anna González-Neira,Grethe I Grenaker Alnæs,Mervi Grip,Pascal Guénel,Lothar Haeberle,Eric Hahnen,Christopher A Haiman,Niclas Håkansson,Per Hall,Ute Hamann,Susan Hankinson,Elaine F Harkness,Patricia A Harrington,Steven N Hart,Jaana M Hartikainen,Alexander Hein,Peter Hillemanns,Louise Hiller,Bernd Holleczek,Antoinette Hollestelle,Maartje J Hooning,Robert N Hoover,John L Hopper,Anthony Howell,Guanmengqian Huang,Keith Humphreys,David J Hunter,Wolfgang Janni,Esther M John,Michael E Jones,Arja Jukkola-Vuorinen,Audrey Jung,Rudolf Kaaks,Maria Kabisch,Katarzyna Kaczmarek,Michael J Kerin,Sofia Khan,Elza Khusnutdinova,Johanna I Kiiski,Cari M Kitahara,Julia A Knight,Yon-Dschun Ko,Linetta B Koppert,Veli-Matti Kosma,Peter Kraft,Vessela N Kristensen,Ute Krüger,Tabea Kühl,Diether Lambrechts,Loic Le Marchand,Eunjung Lee,Flavio Lejbkowicz,Lian Li,Annika Lindblom,Sara Lindström,Martha Linet,Jolanta Lissowska,Wing-Yee Lo,Sibylle Loibl,Jan Lubiński,Michael P Lux,Robert J MacInnis,Melanie Maierthaler,Tom Maishman,Enes Makalic,Arto Mannermaa,Mehdi Manoochehri,Siranoush Manoukian,Sara Margolin,Maria Elena Martinez,Dimitrios Mavroudis,Catriona McLean,Alfons Meindl,Pooja Middha,Nicola Miller,Roger L Milne,Fernando Moreno,Anna Marie Mulligan,Claire Mulot,Rami Nassir,Susan L Neuhausen,William T Newman,Sune F Nielsen,Børge G Nordestgaard,Aaron Norman,Håkan Olsson,Nick Orr,V Shane Pankratz,Tjoung-Won Park-Simon,Jose I A Perez,Clara Pérez-Barrios,Paolo Peterlongo,Christos Petridis,Mila Pinchev,Karoliona Prajzendanc,Ross Prentice,Nadege Presneau,Darya Prokofieva,Katri Pylkäs,Brigitte Rack,Paolo Radice,Dhanya Ramachandran,Gadi Rennert,Hedy S Rennert,Valerie Rhenius,Atocha Romero,Rebecca Roylance,Emmanouil Saloustros,Elinor J Sawyer,Daniel F Schmidt,Rita K Schmutzler,Andreas Schneeweiss,Minouk J Schoemaker,Fredrick Schumacher,Lukas Schwentner,Rodney J Scott,Christopher Scott,Caroline Seynaeve,Mitul Shah,Jacques Simard,Ann Smeets,Christof Sohn,Melissa C Southey,Anthony J Swerdlow,Aline Talhouk,Rulla M Tamimi,William J Tapper,Manuel R Teixeira,Maria Tengström,Mary Beth Terry,Kathrin Thöne,Rob A E M Tollenaar,Ian Tomlinson,Diana Torres,Thérèse Truong,Constance Turman,Clare Turnbull,Hans-Ulrich Ulmer,Michael Untch,Celine Vachon,Christi J van Asperen,Ans M W van den Ouweland,Elke M van Veen,Camilla Wendt,Alice S Whittemore,Walter Willett,Robert Winqvist,Alicja Wolk,Xiaohong R Yang,Yan Zhang,Douglas F Easton,Peter A Fasching,Heli Nevanlinna,Diana M Eccles,Paul D P Pharoah,Marjanka K Schmidt
DOI: https://doi.org/10.1038/s41416-019-0393-x
Abstract:Background: We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry. Methods: Meta-analyses included summary estimates based on Cox models of twelve datasets using ~10.4 million variants for 96,661 women with breast cancer and 7697 events (breast cancer-specific deaths). Oestrogen receptor (ER)-specific analyses were based on 64,171 ER-positive (4116) and 16,172 ER-negative (2125) patients. We evaluated the probability of a signal to be a true positive using the Bayesian false discovery probability (BFDP). Results: We did not find any variant associated with breast cancer-specific mortality at P < 5 × 10-8. For ER-positive disease, the most significantly associated variant was chr7:rs4717568 (BFDP = 7%, P = 1.28 × 10-7, hazard ratio [HR] = 0.88, 95% confidence interval [CI] = 0.84-0.92); the closest gene is AUTS2. For ER-negative disease, the most significant variant was chr7:rs67918676 (BFDP = 11%, P = 1.38 × 10-7, HR = 1.27, 95% CI = 1.16-1.39); located within a long intergenic non-coding RNA gene (AC004009.3), close to the HOXA gene cluster. Conclusions: We uncovered germline variants on chromosome 7 at BFDP < 15% close to genes for which there is biological evidence related to breast cancer outcome. However, the paucity of variants associated with mortality at genome-wide significance underpins the challenge in providing genetic-based individualised prognostic information for breast cancer patients.